Ventilator-associated pneumonia by multidrug-resistant bacteria: pathogen-specific risks versus care-related risks.
Orhan-Sungur
Mukadder
M
Outcomes Research Institute, Department of Anesthesiology and Perioperative Medicine, University of Louisville, Louisville, KY 40202, USA.
Akça
Ozan
O
D000151:Acinetobacter Infections / Q000453:epidemiology*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002443:Ceftriaxone / Q000627:therapeutic use; D002939:Ciprofloxacin / Q000627:therapeutic use; D024901:Drug Resistance, Multiple, Bacterial; D006801:Humans; D015994:Incidence; D007362:Intensive Care Units; D016015:Logistic Models; D053717:Pneumonia, Ventilator-Associated / Q000453:epidemiology*; D012307:Risk Factors
D000900:Anti-Bacterial Agents; D002939:Ciprofloxacin; D002443:Ceftriaxone